This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
ADDERALL 5 MG TABLET is a brand (anda) product labeled by Teva Pharmaceuticals USA Inc., priced at $12.2426 per EA under NDC 57844010501. Its NADAC has been published 172 times since Jan 7, 2015.
FDA first approved this application on Feb 11, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
ADDERALL 5 MG TABLET
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
57844010501
Classification
Brand (ANDA)
Dosage Form
TABLET
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040422FDA Approved
2/11/2002
TE Code
AB
On Market Since
11/13/2014
Pharmacological Classes
Price Statistics
The NADAC for ADDERALL 5 MG TABLET has been published 172 times since Jan 7, 2015, and over the history we have for it it has risen 155.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.2426 per EA |
|---|---|
| All-time high | $12.2426 (Aug 19, 2026) |
| All-time low | $4.7993 (Jan 7, 2015) |
| 52-week high | $12.2426 |
| 52-week low | $11.1907 |
| Median price | $10.2597 |
| Average price | $9.2102 |
| Largest weekly change | +113.5% (May 22, 2024) |
| Weeks tracked | 172 |
| Tracking since | Jan 7, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ADDERALL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ADDERALL 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $12.2426 per EA (NDC 57844010501), effective Aug 19, 2026.
How has the price of ADDERALL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ADDERALL 5 MG TABLET has risen 155.1%. It has been tracked across 172 weekly CMS publications since Jan 7, 2015.
What are the highest and lowest recorded NADAC prices for ADDERALL 5 MG TABLET?
Since Jan 7, 2015, the NADAC for ADDERALL 5 MG TABLET has ranged from a low of $4.7993 (Jan 7, 2015) to a high of $12.2426 (Aug 19, 2026), with a median of $10.2597 per EA.
Are there cheaper alternatives to ADDERALL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ADDERALL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ADDERALL 5 MG TABLET?
ADDERALL 5 MG TABLET (NDC 57844010501) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a brand (anda) product.
Is ADDERALL 5 MG TABLET in shortage?
Yes — NDC 57844010501 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).